Home · Compare

Eric Venker vs Mayukh Sukhatme

💰 How does your salary compare?

See how you rank against the world's top executives — free, instant, SEC-backed data

Mayukh Sukhatme earned $240.1M (2033%) more than Eric Venker in their most recent fiscal years on record.

Eric VenkerMayukh Sukhatme

CompanyRoivant SciencesRoivant Sciences

TitlePresident and Immunovant CEOPresident and Chief Investment Officer

IndustryHealthcareHealthcare

Fiscal YearFY2024FY2024

Total Pay$11.8M$251.9M

Base Salary$600,208$550,000

Stock Awards$5.1M$170.2M

Bonus$6.0M$81.1M

Data Source: Figures are sourced from each executive's most recent DEF 14A proxy filing on record with the SEC. See something wrong? Report it.

← Back to database · Eric Venker's full profile · Mayukh Sukhatme's full profile

ExecSalaries.com · Data sourced from SEC EDGAR DEF 14A proxy filings. · Home · About · Privacy Policy